Skip to main content
SpringerLink
Log in

HIF-Prolylhydroxylase-Hemmung – eine interessante Alternative zur Behandlung der renalen Anämie mit Erythropoetinanaloga?

HIF prolyl hydroxylase inhibition – an interesting alternative for erythropoietin analogue treatment of renal anemia?

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Rabinowitz MH (2013) Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses. J Med Chem 56:9369–9402

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schwerpunkt Nephrologie, I. Medizinische Klinik und Poliklinik, Universitätsmedizin Mainz, Langenbbeckstr. 1, 55131, Mainz, Deutschland

    J. Lutz

Authors
  1. J. Lutz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Lutz.

Ethics declarations

Interessenkonflikt

J. Lutz gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

T. Feldkamp, Kiel

J. Lutz, Mainz

L.T. Weber, Köln

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lutz, J. HIF-Prolylhydroxylase-Hemmung – eine interessante Alternative zur Behandlung der renalen Anämie mit Erythropoetinanaloga?. Nephrologe 11, 146–147 (2016). https://doi.org/10.1007/s11560-015-0045-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-015-0045-y

Search

Navigation